The modulation of prostate cancer risk with α-tocopherol: A pilot randomized, controlled clinical trial

Journal of Urology

Volumn 174, Issue 2, 2005, Pages 519-522

  Hernández, Javier ^a   Syed, Samira ^c   Weiss, Geoffrey ^b,d   Fernandes, Gabriel ^b   Von Merveldt, Dendra ^a   Troyer, Dean A ^a,d   Basler, Joseph W ^a   Thompson Jr , Ian M ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c CTRC Institute for Drug Development   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Biological; Prostate; Prostate specific antigen; Prostatic neoplasms; Tumor markers; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; PLACEBO; PRASTERONE; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN C; TESTOSTERONE; TUMOR MARKER;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DOUBLE BLIND PROCEDURE; HIGH RISK POPULATION; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 22144492228     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000165151.08560.6a     Document Type: Article

References (19)

1. Recent trends in mortality rates for four major cancers, by sex and race/ethnicity-United States, 1990-1998. Morb Mortal Wkly Rep, 51: 49, 2002
2. Catalona, W. J., Richie, J. P., Ahmann, F., Hudson, M. A., Scardino, P. T., Flanigan R. C. et al: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol, 151: 1283, 1994
3. Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G. et al: The influence of finasteride on the development of prostate cancer. N Engl J Med, 349: 215, 2003
4. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R. et al: SELECT: the selenium and vitamin E cancer prevention trial. Urol Oncol, 21: 59, 2003
5. Pappas, A. M.: Vitamin E: tocopherols and tocotrienols. In: Antioxidant Status, Diet, Nutrition, and Health. Boca Raton: CRC Press, 1999
6. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R. et al: SELECT: the next prostate cancer prevention trial. J Urol, 166: 1311, 2001
7. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med, 330: 1029, 1994
8. Heinonen, O. P., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J. K., Hartman, A. M. et al: Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 90: 440, 1998
9. Fleshner, N. E. and Kucuk, O.: Antioxidant dietary supplements: rationale and current status as chemopreventive agents for prostate cancer. Urology, suppl., 57: 90, 2001
10. Mahoney, C. W. and Azzi, A.: Vitamin E inhibits protein kinase C activity. Biochem Biophys Res Commun, 154: 694, 1988
11. Wang, W. and Higuchi, C. M: Induction of NAD(P)H: quinone reductase by vitamins A, E and C in Colo205 colon cancer cells. Cancer Lett, 98: 63, 1995
12. Ottino, P. and Duncan, J. R.: Effect of alpha-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. Free Radic Biol Med, 22: 1145, 1997
13. Traber, M. G. and Packer, L.: Vitamin E: beyond antioxidant function. Am J Clin Nutr, 62: 1501S, 1995
14. Hartman, T. J., Dorgan, J. F., Virtamo, J., Tangrea, J. A., Taylor, P. R. and Albanes, D.: Association between serum alpha-tocopherol and serum androgens and estrogens in older men. Nutr Cancer, 35: 10, 1999
15. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R. and Dagenais, G.: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 342: 145, 2000
16. Sakamoto, W., Fujie, K., Nishihira, J., Mino, M., Morita, I. and Murota, S.: Inhibition of PGE2 production in macrophages from vitamin E-treated rats. Prostaglandins Leukot Essent Fatty Acids, 44: 89, 1991
17. Iwamura, M., Sluss, P. M., Casamento, J. B. and Cockett, A. T.: Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate, 22: 243, 1993
18. Mantzoros, C. S., Tzonou, A., Signorello, L. B., Stampfer, M., Trichopoulos, D. and Adami, H. O.: Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer, 76: 1115, 1997
19. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P. et al: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279: 563, 1998